Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 1058165, 7 pages
http://dx.doi.org/10.1155/2016/1058165
Research Article

CD3+CD8+CD28 T Lymphocytes in Patients with Lupus Nephritis

Department and Clinic of Nephrology and Transplantation Medicine, Faculty of Postgraduate Medical Training, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland

Received 24 February 2016; Revised 28 April 2016; Accepted 1 June 2016

Academic Editor: Oscar Bottasso

Copyright © 2016 Marcelina Żabińska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Nagata and Y. Koide, “Induction of specific CD8+ T cells against intracellular bacteria by CD8+ T-cell-oriented immunization approaches,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 764542, 11 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. T. R. Mempel and C. A. Bauer, “Intravital imaging of CD8+ T cell function in cancer,” Clinical and Experimental Metastasis, vol. 26, no. 4, pp. 311–327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Strioga, V. Pasukoniene, and D. Characiejus, “CD8+CD28 and CD8+CD57+ T cells and their role in health and disease,” Immunology, vol. 134, no. 1, pp. 17–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. C. Boesteanu and P. D. Katsikis, “Memory T cells need CD28 costimulation to remember,” Seminars in Immunology, vol. 21, no. 2, pp. 69–77, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Kaech, E. J. Wherry, and R. Ahmed, “Effector and memory T-cell differentiation: implications for vaccine development,” Nature Reviews Immunology, vol. 2, no. 4, pp. 251–262, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. A. N. Vallejo, “CD28 extinction in human T cells: altered functions and the program of T-cell senescence,” Immunological Reviews, vol. 205, pp. 158–169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Cohen, D. Janicki-Deverts, R. B. Turner et al., “Association between telomere length and experimentally induced upper respiratory viral infection in healthy adults,” The Journal of the American Medical Association, vol. 309, no. 7, pp. 699–705, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S.-H. Kim, P. Kaminker, and J. Campisi, “Telomeres, aging and cancer: in search of a happy ending,” Oncogene, vol. 21, no. 4, pp. 503–511, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Holliday, “Telomeres and telomerase: the commitment theory of cellular ageing revisited,” Science Progress, vol. 95, no. 2, pp. 199–205, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Haque, C. Rakieh, F. Marriage et al., “Brief report: shortened telomere length in patients with systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 65, no. 5, pp. 1319–1323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Honda, E. Mengesha, S. Albano et al., “Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28lo T cells in patients with systemic lupus erythematosus,” Cellular Immunology, vol. 208, no. 2, pp. 211–221, 2001. View at Google Scholar · View at Scopus
  12. I. Colmegna, A. Diaz-Borjon, H. Fujii, L. Schaefer, J. J. Goronzy, and C. M. Weyand, “Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 58, no. 4, pp. 990–1000, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. M. Artlett, C. M. Black, D. C. Briggs, C. O. Stevens, and K. I. Welsh, “Telomere reduction in scleroderma patients: a possible cause for chromosomal instability,” British Journal of Rheumatology, vol. 35, no. 8, pp. 732–737, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Vogt, C. Iking-Konert, F. Hug, K. Andrassy, and G. M. Hänsch, “Shortening of telomeres: evidence for replicative senescence of T cells derived from patients with Wegener's granulomatosis,” Kidney International, vol. 63, no. 6, pp. 2144–2151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Wu, N. Higashi, E. R. Hansen, M. Lund, K. Bang, and K. Thestrup-Pedersen, “Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis,” Journal of Immunology, vol. 165, no. 8, pp. 4742–4747, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Montoya-Ortiz, “Immunosenescence, aging, and systemic lupus erythematous,” Autoimmune Diseases, vol. 2013, Article ID 267078, 15 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Agrawal, A. Sridharan, S. Prakash, and H. Agrawal, “Dendritic cells and aging: consequences for autoimmunity,” Expert Review of Clinical Immunology, vol. 8, no. 1, pp. 73–80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Focosi, M. Bestagno, O. Burrone, and M. Petrini, “CD57+ T lymphocytes and functional immune deficiency,” Journal of Leukocyte Biology, vol. 87, no. 1, pp. 107–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. N. J. Borthwick, M. Lowdell, M. Salmon, and A. N. Akbar, “Loss of CD28 expression on CD8+ T cells in induced by IL-2 receptor γ chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis,” International Immunology, vol. 12, no. 7, pp. 1005–1013, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. K. L. Wood, H. L. Twigg III, and A. I. Doseff, “Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation,” Frontiers in Bioscience, vol. 14, no. 10, pp. 3771–3781, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Spaulding, W. Guo, and R. B. Effros, “Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation,” Experimental Gerontology, vol. 34, no. 5, pp. 633–644, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. R. B. Effros, “Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress,” Experimental Gerontology, vol. 46, no. 2-3, pp. 135–140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Mikulkova, P. Praksova, P. Stourac et al., “Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis,” Cellular Immunology, vol. 262, no. 2, pp. 75–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Sun, W. Zhong, X. Lu et al., “Association of Graves' disease and prevalence of circulating IFN-γ-producing CD28 T cells,” Journal of Clinical Immunology, vol. 28, no. 5, pp. 464–472, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. E. C. Y. Wang, T. M. Lawson, K. Vedhara, P. A. H. Moss, P. J. Lehner, and L. K. Borysiewicz, “CD8high+ (CD57+) T cells in patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 40, no. 2, pp. 237–248, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Scarsi, T. Ziglioli, and P. Airo, “Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical response,” Journal of Rheumatology, vol. 37, no. 5, pp. 911–916, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Frisullo, V. Nociti, R. Iorio et al., “CD8+Foxp3+ T cells in peripheral blood of relapsing-remitting multiple sclerosis patients,” Human Immunology, vol. 71, no. 5, pp. 437–441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. S. Manavalan, S. Kim-Schulze, L. Scotto et al., “Alloantigen specific CD8+ CD28 FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity,” International Immunology, vol. 16, no. 8, pp. 1055–1068, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Korecka-Polak, A. Duszota, P. Wierzbicki et al., “Human peripheral blood CD8+ CD28- T cells of renal allograft recipients do not express FOXP3 protein,” Transplantation Proceedings, vol. 43, no. 8, pp. 2917–2921, 2011. View at Publisher · View at Google Scholar
  30. L. Scotto, A. J. Naiyer, S. Galluzzo et al., “Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28 T suppressor cells,” Human Immunology, vol. 65, no. 11, pp. 1297–1306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Baeten, S. Louis, C. Braud et al., “Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients,” Journal of the American Society of Nephrology, vol. 17, no. 1, pp. 294–304, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Alvarado-Sánchez, B. Hernández-Castro, D. Portales-Pérez et al., “Regulatory T cells in patients with systemic lupus erythematosus,” Journal of Autoimmunity, vol. 27, no. 2, pp. 110–118, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Tulunay, S. Yavuz, H. Direskeneli, and E. Eksioglu-Demiralp, “CD8+CD28, suppressive T cells in systemic lupus erythematosus,” Lupus, vol. 17, no. 7, pp. 630–637, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Bombardier, D. D. Gladman, M. B. Urowitz et al., “Derivation of the SLEDAI: a disease activity index for lupus patients,” Arthritis and Rheumatism, vol. 35, no. 6, pp. 630–640, 1992. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Griffiths, M. Mosca, and C. Gordon, “Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices,” Best Practice and Research: Clinical Rheumatology, vol. 19, no. 5, pp. 685–708, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Blanco, V. Pitard, J.-F. Viallard, J.-L. Taupin, J.-L. Pellegrin, and J.-F. Moreau, “Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 52, no. 1, pp. 201–211, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. K. L. Wood, K. S. Knox, Y. Wang, R. B. Day, C. Schnizlein-Bick, and H. L. Twigg III, “Apoptosis of CD57+ and CD57- lymphocytes in the lung and blood of HIV-infected subjects,” Clinical Immunology, vol. 117, no. 3, pp. 294–301, 2005. View at Publisher · View at Google Scholar · View at Scopus